Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial
Ali Ghaleiha(Hamedan University of Medical Sciences), Shahin Akhondzadeh(Arak University of Medical Sciences), Noorollah Yadegari(Roozbeh Hospital), Habibeh Yekehtaz(Arak University of Medical Sciences), Mina Tabrizi(Tehran University of Medical Sciences), Mehdi Farokhnia(National Institutes of Health), Reza Hajiaghaee, Mohammad-Reza Mohammadi(Roozbeh Hospital), Mohammad Ghyasvand(Roozbeh Hospital)
Cited by 88
Related Papers
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151